Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 8.15 -3.09% -0.26
INSY closed down 3.09 percent on Friday, June 22, 2018, on 1.5 times normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical INSY trend table...

Date Alert Name Type % Chg
Jun 22 Upper Bollinger Band Walk Strength 0.00%
Jun 22 Wide Bands Range Expansion 0.00%
Jun 21 Calm After Storm Range Contraction -3.09%
Jun 21 NR7 Range Contraction -3.09%
Jun 21 Upper Bollinger Band Walk Strength -3.09%
Jun 21 Wide Bands Range Expansion -3.09%
Jun 21 Above Upper BB Strength -3.09%
Jun 21 Up 3 Days in a Row Strength -3.09%
Jun 21 Upper Bollinger Band Touch Strength -3.09%
Jun 20 Upper Bollinger Band Walk Strength -1.09%

Older signals for INSY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.0
52 Week Low 4.1
Average Volume 751,862
200-Day Moving Average 7.3891
50-Day Moving Average 7.0524
20-Day Moving Average 7.2935
10-Day Moving Average 7.78
Average True Range 0.4826
ADX 21.54
+DI 31.41
-DI 14.96
Chandelier Exit (Long, 3 ATRs ) 7.4422
Chandelier Exit (Short, 3 ATRs ) 7.8678
Upper Bollinger Band 8.5213
Lower Bollinger Band 6.0657
Percent B (%b) 0.85
BandWidth 33.668335
MACD Line 0.3563
MACD Signal Line 0.2341
MACD Histogram 0.1222
Fundamentals Value
Market Cap 592.48 Million
Num Shares 72.7 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -37.05
Price-to-Sales 2.18
Price-to-Book 1.57
PEG Ratio -0.62
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.83
Resistance 3 (R3) 8.86 8.67 8.71
Resistance 2 (R2) 8.67 8.50 8.65 8.67
Resistance 1 (R1) 8.41 8.39 8.32 8.38 8.64
Pivot Point 8.22 8.22 8.17 8.20 8.22
Support 1 (S1) 7.96 8.05 7.87 7.93 7.66
Support 2 (S2) 7.77 7.94 7.75 7.63
Support 3 (S3) 7.51 7.77 7.59
Support 4 (S4) 7.48